Selective alteration of immunocompetence with methotrexate and 5-fluorouracil.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000936:Antigen-Antibody Complex; D003877:Dermatitis, Contact / Q000276:immunology; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology*; D006084:Graft Rejection / Q000187:drug effects; D006462:Hemolytic Plaque Technique; D006967:Hypersensitivity; D007111:Immunity, Cellular / Q000187:drug effects*; D007075:Immunoglobulin M / Q000032:analysis; D007165:Immunosuppression Therapy; D002955:Leucovorin / Q000494:pharmacology; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D010080:Oxazoles; D012710:Serum Albumin, Bovine; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000936:Antigen-Antibody Complex; D007075:Immunoglobulin M; D010080:Oxazoles; D012710:Serum Albumin, Bovine; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate